Bristol-Myers Squibb Company PFD CONV 2
OTC: BMYMP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Christopher S. Boerner
- Employees
- 34,100
- Headquarters
- Princeton, United States
- IPO year
- 2003
- Market cap
- $814.6B
- Website
- http://www.bms.com
Loading BMYMP…
Loading profile data…Frequently asked questions about BMYMP
What does Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) do?
Bristol-Myers Squibb is a pharmaceutical company dedicated to the research, development, and commercialization of treatments for a wide array of medical conditions. Its primary therapeutic domains include cardiovascular health, oncology, and immunological disorders. A significant strategic emphasis for the firm is immuno-oncology, an area where...
Where does BMYMP trade?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) trades on the Other OTC.
What sector is BMYMP in?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Bristol-Myers Squibb Company PFD CONV 2?
Christopher S. Boerner is the chief executive officer of Bristol-Myers Squibb Company PFD CONV 2 (BMYMP).
Where is Bristol-Myers Squibb Company PFD CONV 2 headquartered?
Bristol-Myers Squibb Company PFD CONV 2 is headquartered in United States.
Does BMYMP pay a dividend?
Yes — Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) paid a trailing twelve-month dividend of USD 1.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BMYMP go public?
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) completed its initial public offering in 2003.
Is BMYMP an ADR?
Yes — BMYMP is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Bristol-Myers Squibb Company PFD CONV 2 reporting and dividends follow the underlying issuer.